Investors Watch List: Schlumberger Limited (NYSE:SLB), CafePress Inc. (NASDAQ:PRSS), Village Super Market Inc. (NASDAQ:VLGEA), Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), Xylem Inc. (NYSE:XYL)

Technology Stocks News 8

Zacks reissued their neutral rating on shares of Schlumberger Limited. (NYSE:SLB) in a research report sent to investors on Monday morning. The firm currently has a $104.00 price target on the stock. Schlumberger Limited (NYSE:SLB) belongs to Basic Materials sector. Its net profit margin is 14.20% and weekly performance is -2.31%. On last trading day company shares ended up $92.81. Schlumberger Limited (NYSE:SLB) distance from 50-day simple moving average (SMA50) is -4.64%.

On Nov 13, CafePress Inc. (NASDAQ:PRSS) reported financial results for the three months ended September 30, 2014. Net revenues totaled $48.6 million, compared to $50.4 million in the third quarter of 2013. CafePress Inc. (NASDAQ:PRSS) shares decreased -1.41% in last trading session and ended the day at $2.10. PRSS Gross Margin is 37.30% and its return on assets is -13.10%. CafePress Inc. (NASDAQ:PRSS) quarterly performance is -45.60%.

Village Super Market (NASDAQ:VLGEA) major shareholder Of Perry Sumas Estate unloaded 1,854 shares of Village Super Market stock on the open market in a transaction dated Monday, November 24th. The shares were sold at an average price of $25.09, for a total transaction of $46,516.86. Following the sale, the insider now directly owns 1,213,138 shares in the company, valued at approximately $30,437,632. On 26 November, Village Super Market Inc. (NASDAQ:VLGEA) shares decreased -0.32% and was closed at $24.75. VLGEA EPS growth in last 5 year was -29.40%. Village Super Market Inc. (NASDAQ:VLGEA) year to date (YTD) performance is -17.66%.

The FDA has declined to approve Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) investigational drug-device combination product AVP-825 for the treatment of migraine. Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) belongs to Healthcare sector. Its net profit margin is -68.90% and weekly performance is 10.61%. On last trading day company shares ended up $15.01. Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) distance from 50-day simple moving average (SMA50) is 21.82%.

Xylem Inc. (NYSE:XYL), announced that its President and Chief Executive Officer Patrick Decker, Chief Financial Officer Mike Speetzen and Vice President of Investor Relations Phil DeSousa presented at the Baird 2014 Industrial Conference at the Four Seasons Hotel in Chicago on November 11. Xylem Inc. (NYSE:XYL) shares advanced 0.39% in last trading session and ended the day at $38.54. XYL Gross Margin is 38.80% and its return on assets is 6.30%. Xylem Inc. (NYSE:XYL) quarterly performance is 4.16%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone